Dear Colleagues,

We are pleased to share the peer-reviewed highlights of the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), held in Copenhagen, Denmark, from April 25 to 28, 2015.

MD Conference Express® provides timely, peer-reviewed highlights of high-impact presentations from the live conference, long before they are published in the academic literature, and it is a trusted education resource. The articles selected for this issue underwent a rigorous 5-step peer-review process to ensure their accuracy and provide a reliable interim information source prior to the research being vetted by the standard journal peer-review process.

The articles in this issue of MD Conference Express represent the most compelling topics of relevance to a broad array of practitioners and have the potential to influence clinical practice.

Among the clinical trial highlights from ECCMID is the REPRISE trial, showing that ceftazidime-avibactam effectively treated urinary tract infections caused by gram-negative bacteria. Pooled data from the RECLAIM 1 and 2 studies showed that the combination of ceftazidime-avibactam and metronidazole was noninferior to meropenem for treating complicated intra-abdominal infections.

Interferon-free strategies for treating hepatitis C and the issue of antimicrobial resistance are the focus of the feature articles. The selected update articles include a review of rapid diagnostics.

We hope that you find the articles and practical perspectives that are contained in the pages of this issue of MD Conference Express helpful in integrating this new information into your clinical practice. For more information, please visit mdce.sagepub.com.